15 Apr


Dr. François Gilardoni

François Gilardoni, PhD, WID Co-founder
François Gilardoni is a venture capitalist, innovation expert and award-winning scientist educated in Switzerland and the USA with nearly two decades of international experience (EMEA, USA and Japan) in the high-tech and financial industries. He sits on the board of directors of several invested companies and advises IT, ICT, healthcare and cleantech companies. Building on the success of the first Innovation Day (ID) held in Geneva in 2007, in 2012 he partnered with Prof. Didier Pittet, world renowned specialist in patient safety, to foster a global culture of innovation in Medical and Healthcare Science by promoting IDs around the world. In 2013, they launched the World Innovation Day (WID) global initiative. Francois has further launched the World Innovation Academy (WIA), an affiliate fund to guide entrepreneurs in bringing disruptive enabling technologies to a global market. These technologies are issued from and are deployed within WIA’s global collaborative development network. He is founder of Global Advisory Services (GlobAS), a boutique firm providing non-discretionary investment advisory services to clients seeking to expand their private equity portfolio in the high-tech industry and to ventures raising capital (debt or equity). Francois holds a PhD (cum laude) in Computational Chemistry, as well as advanced degrees in Environmental Science and Computing. He was awarded the prestigious Swiss Prix LATSIS for his achievements in computational chemistry.  He holds one patent issued to Avantium Technologies BV and has authored over 30 scientific publications in highly ranked international journals and technical conference presentations. @GilardoniF

Tiese Manigo Gilardoni

Tiese Manigo Gilardoni,  WID Co-founder
Tiese MANIGO GILARDONI is WID’s founding COO and Head of Strategy. She has over fifteen years of international business experience and is the founder and principal of duMonde, LLC. Her forte is in understanding the nuts and bolts of a business, as well as the socio-economic, developmental, cultural, brand and legal implications of investing and deploying in specific markets. She negotiates on behalf of and/or against governments, startups, SMEs and the world’s largest multinational corporations in the U.S., Europe, the Middle East and S. Africa. She guides decision makers and stakeholders with differing perspectives, i.e. technical, business, legal, policy, and public/private sectors. Her clients are startups, SMEs, legal firms, EMEA Government and private sector investors, spanning the IT, ICT, Healthcare, Cleantech, Electronics and e-commerce Industries. Tiese has an LL.M. in European & International Economic Law (Universities of Lausanne), a Master’s degree in International Law, International Relations, Diplomacy (SOAS, CISD), and a BA in Spanish Language and Literature (Davidson College).@MediaduM

Prof. Didier Pittet

Didier Pittet, MD, MS, WID Co-founder
Dr. Didier Pittet is Professor of Medicine, Hospital Epidemiologist and Director of the Infection Control Programme and World Health Organization (WHO) Collaborating Centre on Patient Safety at the University of Geneva Hospitals (HUG) and Faculty of Medicine, Geneva, Switzerland. He holds Honorary Professorships at Imperial College London, UK, Hong Kong Polytechnic University School of Health and Social Sciences and at the Medical Center of Fudan University, Shanghai, China. Professor Pittet is Lead Advisor of the first WHO Global Patient Safety Challenge, “Clean Care is Safe Care”, and the African Partnerships for Patient Safety at WHO Headquarters. He is the recipient of several national and international honors, including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK (2007), the Society for Healthcare Epidemiology of America Lectureship for his contribution to infection control and healthcare epidemiology (2008), and the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009). Professor Pittet is co-author of more than 500 publications in peer-reviewed journals and 50 textbook chapters. He serves on the editorial boards of a number of journals, including The Lancet Infectious Diseases, the American Journal of Infection Control, Antimicrobial Resistance and Infection Control, and Infection Control and Hospital Epidemiology. He is also an editorial consultant at The Lancet. His current research interests include the epidemiology and prevention of healthcare-associated infections, methods for improving compliance with barrier precautions and hand hygiene practices, as well as innovative methods for improving the quality of patient care and patient safety. He is also involved in research on the epidemiology of infectious diseases, and public and global health issues. The experience of his team in engaging nations and healthcare facilities worldwide in a universal commitment to patient safety is unique. A leader in his field, Dr. Pittet launched the first Innovation Day at HUG in 2007 and is co-founder of WID. A novel about his pioneering work around hand hygiene, entitled Clean Hands Save Lives,  was released this year. @DidierPittet

27 Mar


The WID-I4H Competition will be held at the prestigious “Campus Biotech” in Geneva, Switzerland on August 28th and 29th, 2014.  Twelve teams from Africa, Asia, Europe and North America – the champions at their local Innovation Days – will compete for the Innovation for Health Award of Excellence.